Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger A, Almqvist P, Wahlberg L. Eriksdotter-Jönhagen M, et al. Among authors: lind g. Dement Geriatr Cogn Disord. 2012;33(1):18-28. doi: 10.1159/000336051. Epub 2012 Feb 22. Dement Geriatr Cogn Disord. 2012. PMID: 22377499
Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery.
Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, Linderoth B. Wahlberg LU, et al. Among authors: lind g. J Neurosurg. 2012 Aug;117(2):340-7. doi: 10.3171/2012.2.JNS11714. Epub 2012 Jun 1. J Neurosurg. 2012. PMID: 22655593 Clinical Trial.
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, Nordberg A, Wahlberg L, Darreh-Shori T, Eriksdotter M. Karami A, et al. Among authors: lind g. Alzheimers Dement. 2015 Nov;11(11):1316-28. doi: 10.1016/j.jalz.2014.11.008. Epub 2015 Feb 9. Alzheimers Dement. 2015. PMID: 25676388
Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P. Eyjolfsdottir H, et al. Among authors: lind g. Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9. Alzheimers Res Ther. 2016. PMID: 27389402 Free PMC article. Clinical Trial.
The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.
Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger Å, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M; Alzheimer’s Disease Neuroimaging Initiative. Machado A, et al. Among authors: lind g. Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7. Alzheimers Res Ther. 2020. PMID: 32375872 Free PMC article. Clinical Trial.
Fast Alpha Activity in EEG of Patients With Alzheimer's Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor.
Eyjolfsdottir H, Koenig T, Karami A, Almqvist P, Lind G, Linderoth B, Wahlberg L, Seiger Å, Darreh-Shori T, Eriksdotter M, Jelic V. Eyjolfsdottir H, et al. Among authors: lind g. Front Aging Neurosci. 2022 Apr 25;14:756687. doi: 10.3389/fnagi.2022.756687. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35557841 Free PMC article.
155 results